Cite
MLA Citation
M. Xipell et al.. “Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.” Oncoimmunology, vol. 7, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100065072176.0x000002